🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Adaptive Radiotherapy

This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned. NCT05946824Phase 21 site📍 Rochester University of Rochester · Tests: Daily-adaptive Stereotactic Body Radiation Therapy, Daily-adaptive Stereotactic Body Radiation Therapy MR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer NCT06840665Phase 21 site📍 Shanghai Fudan University · Tests: PD-1 antibody, Oxaliplatin, Capecitabine Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer NCT07189598NA1 site📍 Rennes Center Eugene Marquis · Tests: Adaptive Stereostatic Body RadioTherapy (SBRT) including both Whole Pelvic RadioTherapy (WPRT) and dose-escalation on t… Stereotactic MR-Adaptive Radiation Therapy for Early-stage Renal Cancer NCT07767500NA1 site📍 New York NYU Langone Health · Tests: MRI-guided linear accelerator, Magnetic resonance imaging (MRI)-guided radiation therapy (MRgRT) PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM NCT06788171Phase 21 site📍 Fuzhou Fujian Cancer Hospital · Tests: Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy, Bevacizumab, Capecitabine, Oxaliplatin, Sintilimab REGULUS: MRI-guided Adaptive SABR for Liver Cancers NCT07223307Phase 21 site📍 Palo Alto Stanford University · Tests: MRI-guided adaptive stereotactic ablative body radiotherapy (SABR) Adaptive Radiation for Abdominopelvic Metastases NCT05880667Phase 11 site📍 Philadelphia Fox Chase Cancer Center · Tests: Adaptive Stereotactic Body Radiation Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma NCT03215719Phase 21 site📍 New York NYU Langone Health · Tests: Standard Radiation Treatment, Dose-Deescalated Treatment, Cisplatinum A Study of Short-course Hypofractionated Online-adaptive Radiotherapy for the Post-operative Treatment of Endometrial Cancer: Tolerability and Feasibility NCT07675733NA1 site📍 Sutton Royal Marsden NHS Foundation Trust · Tests: Hypofractionated CT online adaptive radiotherapy (CT-OART) with dose of 30 Gray in 5 fractions, over one and a half wee… Adaptive RadioTherapy for OroPharynx Cancer NCT04901234Phase 22 sites📍 Melbourne📍 Montreal Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Standard radiotherapy +/- chemotherapy, Experimental radiotherapy +/- chemotherapy SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer NCT05412082Phase 11 site📍 Miami University of Miami · Tests: Intensity-modulated radiation therapy, 5-fluorouracil, Leucovorin, Oxaliplatin, Capecitabine Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases NCT06542159Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Online adaptive SBRT, Conventional SBRT Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction NCT07132190Phase 21 site📍 Boston Ayal A. Aizer, MD · Tests: Linear accelerator-based stereotactic radiation for brain metastases using 0mm or 1mm PTV OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases NCT04020276NA1 site📍 Madison University of Wisconsin, Madison · Tests: SBRT Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer NCT05833867Phase 11 site📍 Cleveland Shilpa Gupta, MD · Tests: Sacituzumab govitecan, Adaptive Radiotherapy Adaptive Radiation Boost for Rectal Cancer NCT07221058Phase 11 site📍 Philadelphia Fox Chase Cancer Center · Tests: Adaptive Radiotherapy Boost Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach NCT05764720NA4 sites📍 Birmingham📍 Duarte📍 St Louis Varian, a Siemens Healthineers Company · Tests: Daily Adaptive External Beam Radiation Therapy Perioperative FLOT(D) With Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Esophageal Cancer NCT07700420Phase 11 site📍 Dallas University of Texas Southwestern Medical Center · Tests: PULSAR- Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy, FLOT (Fluorouracil+Leucovorin+Oxaliplatin+D… Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy NCT05996432EARLY Phase 11 site📍 Nashville Vanderbilt-Ingram Cancer Center · Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), 18F-fluoromisonidazole Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma NCT04771806n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Magnetic Resonance Imaging, Neurocognitive Assessment, Quality-of-Life Assessment, Questionnaire Administration Local Radiotherapy for Urinary Bladder Cancer in Patients Not Eligible for Curative Treatment NCT07524426NA1 site📍 Umeå Umeå University · Tests: Local hypo fractionated adaptive radiotherapy and Standard of Care, Standard of Care (Investigator Choice) Pelvic Cancer Registry for Online Adapted Radiotherapy NCT06185062n/a1 site📍 Göttingen University Medical Center Goettingen MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer NCT07584161NA1 site📍 Beijing Xiaorong Hou · Tests: Moderately fractionated radiotherapy using online adaptive radiotherapy technology, Conventionally fractionated radioth… PET-MRI Esophagus Feasibility Study NCT05796102NA1 site📍 Toronto University Health Network, Toronto · Tests: PET-MRI Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE) NCT06691776NA1 site📍 Amsterdam The Netherlands Cancer Institute · Tests: online CBCT-guided adaptive radiation therapy using a new software Phase II Study of Daily Adaptive Radiotherapy for Submandibular Gland-sparing in Head and Neck Cancer NCT07348887NA1 site📍 Toronto University Health Network, Toronto · Tests: Daily adaptive radiation therapy, Image guided radiation therapy Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma NCT05301283Phase 21 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Intensity Modulated Radiation Therapy (IMRT), MRI Dose Escalated Radiotherapy for Rectal Cancers Using MR-guided Radiotherapy NCT06854679NA1 site📍 Sutton Royal Marsden NHS Foundation Trust · Tests: Radiotherapy dose escalation Stereotactic Magnetic Resonance Guided Radiation Therapy NCT04115254NA2 sites📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: MR-guided Linac Daily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer Patients NCT05884632NA1 site📍 Negrar IRCCS Sacro Cuore Don Calabria di Negrar · Tests: Daily Adaptive RadioTherapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy